Abstract | Introduction:
Narcolepsy type 1 is accompanied by a selective loss of orexin/ hypocretin (hcrt) neurons in the lateral hypothalamus caused by yet unknown mechanisms. Epidemiologic and genetic associations strongly suggest an immune-mediated pathogenesis of the disease. Methods: Results: Using these criteria, 3/15 patients (20%) and 0/13 controls (0%) showed orexin/hcrt-specific CD4+ T-cell proliferation (p = .2262). The heterogeneous reactivity pattern did not allow the identification of a preferential target epitope. Conclusions: A significant role of orexin/hcrt-specific T cells in narcolepsy type 1 patients could not be confirmed in this study. Further studies are needed to assess the exact role of CD4+ T cells and possible target antigens in narcolepsy type 1 patients.
|
Authors | Melanie Ramberger, Birgit Högl, Ambra Stefani, Thomas Mitterling, Markus Reindl, Andreas Lutterotti |
Journal | Sleep
(Sleep)
Vol. 40
Issue 3
(Mar 01 2017)
ISSN: 1550-9109 [Electronic] United States |
PMID | 28364420
(Publication Type: Journal Article)
|
Copyright | © Sleep Research Society 2016. Published by Oxford University Press [on behalf of the Sleep Research Society]. |
Chemical References |
- Intracellular Signaling Peptides and Proteins
- Orexins
|
Topics |
- Adolescent
- Adult
- Aged
- Amino Acid Sequence
- CD4-Positive T-Lymphocytes
(drug effects, immunology, metabolism)
- Cells, Cultured
- Child
- Female
- Humans
- Intracellular Signaling Peptides and Proteins
(genetics, pharmacology)
- Leukocytes, Mononuclear
(drug effects, immunology, metabolism)
- Male
- Middle Aged
- Narcolepsy
(blood, immunology)
- Neurons
(drug effects, immunology, metabolism)
- Orexins
(genetics, pharmacology)
- Young Adult
|